Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts

Radioimmunotherapy has shown that the use of monoclonal antibodies combined with a radioisotope like (131)I or (90)Y still remains ineffective for solid and radioresistant tumour treatment. Previous simulations have revealed that an increase in the number of (90)Y labelled to each antibody or nanoob...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas, S., Feron, O., Gallez, B., Masereel, B., Michiels, C., Vander Borght, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469173/
https://www.ncbi.nlm.nih.gov/pubmed/26136812
http://dx.doi.org/10.1155/2015/284360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469173/
https://www.ncbi.nlm.nih.gov/pubmed/26136812
http://dx.doi.org/10.1155/2015/284360

Ejemplares similares